Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline Add-on to Glatiramer Acetate in RR-MS
NCT00203112Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jun 2004
- Primary completion
- Jun 2006
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in relapsing-remitting multiple sclerosis (RRMS) comparing GA + Minocycline with GA + Placebo (2 arms). Primary endpoint: Number of MRI T1 Gd-enhancing lesions at 24 months. Started Jun 2004; status: completed.
02
Drugs
minocycline
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00203112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00203112.